一种快速筛选有效RNAi片段的方法

目的:介绍一种快速筛选有效RNAi片段的方法.方法:构建CC趋化因子配体2(chemokine(C-C motif)ligand 2,CCL2)的表达载体、干涉载体和检验载体;计算检验载体的绿色荧光蛋白(GFP)阳性细胞率;Real-time PCR检测干涉载体的干涉效果;计算PH 72h和168h转基因大鼠的肝再生率.结果:检验载体及其对照在24h表达GFP的细胞数最多,其中检验载体CCL2-CCL2(255)在各时间点的表达量均最低;Real-time PCR结果显示干涉载体CCL2(255)干涉效果较好;表达载体CCL2-N1能提高转基因大鼠PH 168h的肝再生率,达105%,而干涉载体CCL2(255)仅78%,与对照均有显著差异.结论:将靶基因和干涉片段构建到同一个载体上,通过观察、计算GFP的表达量可快速筛选有效RNAi片段,此法高效经济、省时省力.     

细胞外基质相关基因在大鼠肝再生中表达模式分析

细胞外基质具有维持细胞极性、调节细胞粘附、增殖、组织器官形态、发生、分化等功能。为了进一步在基因转录水平了解细胞外基质在大鼠肝再生中变化和作用, 用搜集网站资料和查阅相关论文等方法获得细胞外基质基因, 用Rat Genome 230 2.0芯片检测它们在大鼠再生肝中表达情况, 用真、假手术比较方法确定肝再生相关基因。初步证实上述97个基因与肝再生相关。其中, 肝再生启动(部分肝切除(parital hepatectomy, PH)后0.5~4 h)、G0/G1过渡(PH后4~6 h)、细胞增殖(PH后6~66 h)、细胞分化和组织结构功能重建(PH后72~168 h)等4个阶段起始表达的基因数为49、19、73、5, 基因总表达的次数为84、51、369、144, 表明相关基因主要在肝再生启动阶段起始表达, 在不同阶段发挥作用。它们表达的相似性分为均上调、上调占优势、均下调、下调占优势、上调和下调相近等5类, 涉及38、21、21、10和7个基因, 共上调411次, 下调186次, 分为24种表达模式, 表明肝再生中细胞生理生化活动具有阶段性、多样性和复杂性。根据细胞外基质相关基因在肝再生中表达变化推测, 肝再生前期纤粘连蛋白形成相关基因表达增强, 肝再生中期胶原形成相关基因表达增强。     

离子交换层析初步分离大鼠肝蛋白水解酶、ADAMs、ACP、AKP和PCNA

用DEAE 离子交换层析法分离 2 /3肝切除 ( partialhepatectomy ,PH)后恢复 4、 3 6和 14 4h的大鼠再生肝及正常肝的蛋白水解酶、ADAMs、ACP、AKP和PCNA ;用SDS PAGE、Western blot、酶复性电泳等方法 ,分析了它们在不同洗脱段中的分布及活性变化 ,为分离与肝再生有关的蛋白 (酶 )提供了资料。     

外源性H2S对糖尿病小鼠肝纤维化的作用及其机制*

目的: 探讨外源性硫化氢(H₂S)对糖尿病小鼠肝纤维化作用及其相关机制。方法: 将 C57 雄性体重为(22±2)g 24只小鼠随机分为3组(n=8):①正常对照组(Control):小鼠腹腔注射生理盐水,注射时间同实验组;②糖尿病模型组(HG):按体重(150 mg/kg)一次性腹腔注射链脲佐菌素(STZ)诱导小鼠建立糖尿病模型;③NaHS 处理组(HG + NaHS):方法同组别②,只是糖尿病模型建立后,腹腔注射NaHS(100 μmol/L·kg·d),每天一次,连续12周。HE染色检测肝细胞损伤;Masson染色检测肝纤维化;Western blot检测相关蛋白胱硫醚-β-合成酶(CBS,内源性H₂S产生的关键酶)、胶原I (Col-I)、胶原III (Col-III)和基质金属蛋白酶-9(MMP-9)的表达。结果: 与对照组比较,糖尿病模型组肝细胞损伤及肝纤维化均显著加重,CBS 蛋白表达显著减少(P＜0.01),Col-I、Col-III和MMP-9蛋白表达均显著增加(P＜0.01)。与糖尿病模型组比较,NaHS处理组肝细胞损伤及肝纤维化均显著减轻、CBS 蛋白表达显著增加、Col-I、Col-III和MMP-9蛋白表达均减少(P＜0.01)。结论: 外源性H₂S可抑制糖尿病小鼠肝纤维化,其机制与降低胶原含量和基质金属蛋白酶-9的表达相关。     

藏红花抗大鼠肝纤维化的实验研究

目的:观察藏红花对实验性大鼠肝纤维化的防治效果,探讨其作用机制.方法:将清洁级雄性大鼠60只随机分为正常对照组、模型对照组、复方丹参组、藏红花组.除正常对照组外,其余3组均予四氯化碳腹腔注射,复方丹参组、藏红花组分别予复方丹参、藏红花溶液灌胃,第8周末处死动物,用放射免疫法检测血清透明质酸、层粘连蛋白、Ⅲ型前胶原和Ⅳ型胶原.肝组织切片HE、MASSON染色,显微镜下观察结果.结果:藏红花组大鼠肝纤维化病理改变较轻,血清透明质酸、层粘连蛋白、Ⅲ型前胶原和Ⅳ型胶原水平下降,与模型对照组差异显著(P<0.05).结论:藏红花具有减少肝纤维化大鼠的胶原沉积,抗肝纤维维化作用.     

NDRG2调控大鼠肝细胞周期的机制

目的:阐明NDRG2(N-Myc downstream-regulated gene2)在大鼠肝再生过程中时肝细胞周期的调控机制.方法:大鼠70%肝切除后收集0 h、8 h、24 h、48 h、72 h、7 d、10 d的再生肝组织,采用Real-time PCR和Western blot方法检测大鼠肝再生过程中NDRG2基因和蛋白的动态变化.流式细胞仪检测腺病毒介导的高表达NDRG2对大鼠正常肝细胞系(BRL)细胞周期的影响.Real.time PCR和Western blot方法检测高表达NDRG2对肝细胞周期调控的分子机制.结果:NDRG2基因和蛋白的表达水平在肝再生达到高峰时明显下降,在肝细胞进入分化期时显著上调;流式细胞仪检测显示BRL细胞中高表达NDRG2 48 h后,G0/G1期细胞百分比从对照组39.30+1.97上升至57.44±2.56,S期从37.66±1.73下降至13.27±2.01,差异有统计学意义(P＜0.05).对周期调控相关分子的检测显示高表达NDRG2对肝细胞周期的影响是通过上调p21,抑制Cyclin E实现的.结论:NDRG2通过影响细胞周期参与调控大鼠肝再生过程.     

脂肪细胞分化相关基因在大鼠再生肝中表达变化

肝脏由多种细胞构成,肝再生与细胞分化密切相关,细胞分化受基因转录水平调控。为在基因转录水平了解脂肪细胞分化基因在大鼠肝再生中作用,本文用搜集网站资料和查阅相关论文等方法获得上述基因,用Rat Genome2302.0芯片检测它们在大鼠肝再生(liver regeneration,LR)中表达情况,将三次检验结果相同或相似、在肝再生中表达变化2倍以上、真手术组和假手术组相比差异显著的基因视为肝再生相关基因。初步证实上述基因中75个基因与肝再生相关。肝再生启动(PH后0.5-4h)、G0/G1过渡(PH后4-6h)、细胞增殖(PH后6-66h)、细胞分化和组织结构功能重建(PH后72-168h)等四个阶段起始表达的基因数为44、13、30和1;基因的总表达次数为88、58、302和90。表明相关基因主要在肝再生启动阶段起始表达,在不同阶段发挥作用。它们共表达上调313次、下调167次,分为43种表达方式。表明肝再生中脂肪细胞发生和分化相关基因活动多样和复杂。根据本文研究结果推测,上述基因不仅调节脂肪细胞分化,而且参与肝再生的生理生化活动。     

大鼠再生肝中hsbp1、hsf1、hsf2、hsp70表达水平改变的分析

在克隆了大鼠热休克因子结合蛋白1基因(hsbp1)全长cDNA基础上,进一步分析它在肝再生中作用。用SD纯系大鼠为材料,按Higgens等方法建立大鼠部分肝切除(PH)模型;用原位杂交等方法分析hsbp1在肝再生中表达变化;用基因表达谱芯片分析hsbp1、hsf1、hsf2和hsp70在肝再生中表达变化。原位杂交和基因表达谱芯片分析表明,PH后6h和66-144h,hsbp1表达发生了有意义上调;8-16h,hsf1表达发生了有意义上调;2-16h,hsf2表达发生了有意义上调;0.5-24h,hsp70表达发生了有意义上调。假手术(只打开腹腔和翻动肝叶,但不进行部分肝切除)后0.5-2h,hsbp1表达发生了有意义下调;8-16h,hsf1表达发生了有意义上调;0-144h,hsf2未发生有意义表达变化;0.5-30h,hsp70表达发生了有意义上调。根据实验结果推测,PH后hsbp1表达上调可增加细胞内HSBP1量,促进生长、发育、分化相关基因表达和再生肝的组织结构功能重建;(假)手术后hsbp1表达下调可减少细胞内HSBP1量,有利于HSF1上调hsp70表达,提高机体和肝脏抗损伤能力。     

地塞米松对大鼠再生肝细胞亚精胺合成酶基因转录的影响

采用原位杂交技术研究地塞米松对大鼠再生肝细胞亚精胺合成酶(spermidine syathase,SPDS)基因表达的影响.结果显示,部分肝切除(partial hepatectomy,PH)后,再生肝细胞mRNA表达量呈现先升高后降低的变化趋势,峰值均出现在PH后9 h.PH 去肾上腺使mRNA水平升高,主要表现在PH后6～12 h;地塞米松处理组SPDS基因表达量明显下降,并且随着地塞米松剂量升高,mRNA表达水平降低.结果表明,地塞米松对早期再生肝细胞SPDS基因表达具有抑制作用.     

趋化因子CCL2对人脐静脉内皮细胞ICAM-1 表达的影响

目的:探讨CC类趋化因子配体2(C-C motif ligand 2,CCL2)对人脐静脉内皮细胞(human umbilical vein endothelial cells,HUVECs)中细胞间粘附分子-1(intercellular adhesion molecule-1,ICAM-1)表达的影响。方法:体外分离培养HUVECs细胞,将HUVECs铺至6孔板中,待细胞融合至80-90%时,将CCL2过表达载体[pc DNA3.1(+)-CCL2]及CCL2小分子干扰RNA(si-RNA)分别转染到HUVECs中,于转染后12 h、24 h和48 h收集细胞进行RNA及蛋白提取。荧光定量PCR方法检测HUVECs中CCL2及ICAM-1基因m RNA表达。Western blotting检测HUVECs中CCL2及ICAM-1蛋白表达。结果:(1)与pc DNA3.1(+)组相比较,pc DNA3.1(+)-CCL2组中CCL2基因m RNA和蛋白水平均显著升高;与si-Control组相比较,si-CCL2组中CCL2基因m RNA和蛋白表达均明显下降。(2)与对照组比较,pc DNA3.1(+)-CCL2组明显增加HUVECs中ICAM-1的m RNA及蛋白表达,而si-CCL2组显著抑制HUVECs中ICAM-1的m RNA及蛋白表达。结论:CCL2能增加HUVECs中ICAM-1基因m RNA和蛋白表达,为深入认识动脉粥样硬化的发病机制提供了理论依据。     

Pretreatment with recombinant human interleukin 2 (rhIL-2) Up-regulates PCNA-positive cells after partial hepatectomy in rat liver

We prepared recombinant human interleukin-2 (rhIL-2) and studied its pretreated influence on liver regeneration and the blood profile in partially (67%) hepatectomized (PH) male Sprague-Dawley rats. Rats were injected in the tail vein with rhIL-2 three times per day for 3 consecutive days and 67% underwent a partial hepatectomy (PH). Five days after the PH, liver tissue and blood samples were analyzed for liver regeneration and hematological changes. The weight of the liver in the rhIL-2 pretreated groups increased in a dose-dependent manner; with the highest treatment (24 × 10⁴ IU/kg), the maximum liver weight of 88.6% was exhibited. The control group showed a gradual increase to 76.3% of the original liver weight. A histological analysis of the liver showed an increase in proliferating cell nuclear antigen (PCNA)-positive cells in rhIL-2 pretreated rat livers. The rate of hepatocyte proliferation also increased significantly in primary cultured rat liver cells following rhIL-2 treatment. These results suggest that pretreatment with rhIL-2 may play adjuvant roles in liver regeneration after PH.     

育阴软肝颗粒剂对肝纤维化大鼠TGF-β1表达的影响

目的：观测育阴软肝颗粒剂对大鼠肝纤维化模型的防治作用及对转化生长因子-β1（TGF-β1）表达的影响。方法：将Wistar大鼠分为6组（n=10）,注射四氯化碳、饲以高脂饲料并饮用20%乙醇6周复制肝纤维化大鼠模型,经6.2~24.8 g/kg育阴软肝颗粒剂干预（qd）6周后,测定肝纤维化大鼠血清丙氨酸氨基转移酶（ALT）、天冬氨酸氨基转移酶（AST）活性、透明质酸（HA）、Ⅲ型前胶原（PCⅢ）、Ⅳ型胶原（C-Ⅳ）及板层素（LN）含量,观测肝组织病理学及肝组织TGF-β1表达的变化,对育阴软肝颗粒剂防治肝纤维作用及机制进行研究。结果：实验第7周,模型组大鼠肝组织出现明显的纤维化病变（P<0.01）;与模型组比较,6.2~24.8g/kg的育阴软肝颗粒剂能明显降低肝指数以及血清ALT、AST活性与HA、PCⅢ、C-Ⅳ、LN含量,缓解肝组织纤维化病理变化,抑制纤维化肝组织TGF-β1的表达（P<0.05,0.01）。结论：育阴软肝颗粒剂对多因素复制肝纤维化大鼠造模具有明显的治疗作用,而抑制TGF-β1的表达可能是其作用机制之一。     

Concurrent changes in sinusoidal expression of laminin and affinity of hepatocytes to laminin during rat liver regeneration.

Distribution of fibronectin, laminin, and collagens type I, III, IV, and V in the lobular regions of regenerating rat liver was studied by indirect immunofluorescence. Little or no laminin was detected in sham-operated controls throughout the experimental period, while it was detected in sinusoids of regenerating liver as early as 6 h after partial hepatectomy (PH). After reaching a maximum at 24 h, it decreased and was barely detectable 6 days after PH. Changes in the other extracellular matrix (ECM) proteins were evident 3 days after PH, but not earlier than 24 h. Hepatocytes isolated from regenerating rat livers were tested in a short term assay for attachment to the substrates coated with the ECM proteins. The attachment of hepatocytes to laminin substrates increased 12 h after PH, reached a maximum at 24 h, and decreased to the control level 6 days after PH, while that of the control remained constant. The attachment to fibronectin substrates was not different between regenerating livers and controls at any time point. The attachment to collagen did not change earlier than 24 h after PH, but increased slightly 3 days after PH. Primary rat hepatocytes cultured on the substrates coated with the ECM proteins were determined for replicative DNA synthesis in response to epidermal growth factor. Both in normal liver and in regenerating liver 24 h after PH, laminin was one of the most effective substrates in supporting the responsiveness of hepatocytes to the growth stimulus. Taken together, these results suggest the importance of hepatocyte-laminin interaction during the early stage of liver regeneration possibly in growth stimulation of hepatocytes and/or maintenance of hepatocyte-specific functions.     

Triiodothyronine stimulates hepatocyte proliferation in two models of impaired liver regeneration

Abstract.  Objectives : Liver regeneration is attenuated in old age and is substantially slower after 90% than after 70% partial hepatectomy (PH). We have previously demonstrated that the proliferative response to a primary mitogen is intact in aged mice, indicating that impaired liver regeneration is not due to loss of proliferative capacity. Here, we have investigated whether mitogenic effects of triiodothyronine (T3) could reverse the impaired regeneration of ageing or 90% hepatectomy, in the rat. Materials and methods : T3 (20 µg/100 g body weight) was administered to 14-month-old rats subjected to 70% PH or to young rats subjected to 90% PH. Cell-proliferative capacity was determined by bromodeoxyuridine incorporation and microscopy and changes of cell cycle-related proteins were analysed by Western blot analysis. Results : Treatment of old intact rats with T3 increased cyclin D₁ expression that was followed by an enhanced proliferative response, the labelling index (LI), being 7.8% versus 1.3% of controls. T3 given before 70% PH stimulated regenerative response (LI was 10.8% versus 2.28%), and expression of cyclin D₁ and proliferating cell nuclear antigen (PCNA) 24 h after PH. Pre-treatment with T3 also improved the regenerative response of the liver after 90% hepatectomy (LI was 27.9% versus 14.2%). Conclusions : These findings show in principle that mitogen-induced hyperplasia could be applied to human therapy in patients with reduced regenerative capacity or massive loss of hepatocytes.